# Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

> **NCT01478971** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 184 (actual)

## Conditions studied

- Chronic Kidney Disease
- Anemia

## Interventions

- **DRUG:** Epoetin
- **DRUG:** Peginesatide

## Key facts

- **NCT ID:** NCT01478971
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2016-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478971, "Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01478971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*